News & Breakthroughs at Siteman
Stay informed with the latest cancer news and breakthroughs from Siteman Cancer Center. Our news feed provides timely updates on research breakthroughs, clinical trials, and community events.
In the Media, Staff/Faculty Update
Murphy to Receive AACR-CRI Lloyd J. Old Award in Cancer Immunology
Recognition honors pioneering discoveries that have paved the way for more effective cancer immunotherapies WashU Medicine researcher Kenneth M. Murphy, MD, PhD, has been named the recipient of the 2026 American Association for Cancer Research (AACR)-Cancer Research Institute (CRI) Lloyd J. Old Award in Cancer Immunology. Murphy, the Eugene Opie First Centennial Professor in pathology and immunology at WashU Medicine and […]
Health & Wellness, In the Media, Patient Resource
For Your Health — What to Know About GLP-1 Drugs for Weight Loss and Health
As many of us know, keeping weight in check can be hard. And national numbers certainly reflect this. Rates of overweight and obesity in the U.S. have steadily climbed since the early 1980s. The impact this has had on health and well-being is very significant. Weight gain and obesity increase the risk of 13 cancers, […]
In the Media, Staff/Faculty Update
NCCN Recognizes Podany as 2026 Young Investigator Award Recipient
WashU Medicine physician-scientist Emily L. Podany, MD, MPHS, has been named a 2026 recipient of a prestigious NCCN Foundation Young Investigator Award, given by the National Comprehensive Cancer Network (NCCN) and NCCN Foundation. Podany is an assistant professor of medicine at WashU Medicine and a medical oncologist who treats patients diagnosed with breast cancer at Siteman Cancer Center, based at Barnes-Jewish […]
Clinical, In the Media, Research
Tumor Markers May Help Doctors Decide Which Head and Neck Cancer Patients Need Immunotherapy Before Surgery
WashU Medicine physician-scientists at Siteman Cancer Center identify a promising way to help guide immunotherapy treatment decisions and enhance patient care Building upon more than a decade of investigator-initiated clinical trials at Siteman Cancer Center, based at Barnes-Jewish Hospital and WashU Medicine, researchers have identified a malignant cell biomarker that may predict which patients will respond to the […]
Clinical, In the Media, Research
Innovative CAR-T cell therapy receives FDA breakthrough therapy designation
Immunotherapy for aggressive T-cell cancers developed by WashU Medicine researchers moves to faster approval pathway A cell-based immunotherapy designed to treat rare and aggressive types of blood cancer has been granted Breakthrough Therapy designation by the U.S. Food and Drug Administration (FDA). Developed by researchers at Washington University School of Medicine in St. Louis, this […]
In the Media, Staff/Faculty Update
Stewart elected to AACR board of directors
Sheila A. Stewart, PhD, associate director for basic science and co-leader of the Mechanisms of Cancer Biology Program at Siteman Cancer Center at Barnes-Jewish Hospital and WashU Medicine, has been elected to the American Association for Cancer Research (AACR) Board of Directors. Stewart, who is also the Gerty Cori Professor and vice chair of the […]
In the Media
Hockey and Hope: Siteman teams up with St. Louis Blues alumni for third annual benefit game
Led by Kelly Chase, the March 27 event brings NHL legends and special guests together to raise funds for cancer research, patient care and lifesaving advances. Siteman Cancer Center is honored to once again be a beneficiary of the annual St. Louis Blues alumni game led by Kelly Chase, returning for its third year on […]
Health & Wellness, Patient Resource, Prevention
For Your Health: At any age, we can cut the risk of colorectal cancer
Recent headlines have pushed colorectal cancer back to the top of news feeds with the unfortunate passing of actor James Van Der Beek. Like Chadwick Bozeman, who died of the disease in 2020, Van Der Beek was diagnosed at a relatively young age — part of a troubling trend. Colorectal cancer is the third most […]
In the Media, Research, Staff/Faculty Update
Grant furthers novel therapeutic approach to glioblastoma
Mosquito-borne Zika virus helps destroy deadly brain cancer in mice Milan G. Chheda, MD, an associate professor of medicine in the Division of Oncology at WashU Medicine and a brain tumor specialist at Siteman Cancer Center, based at Barnes-Jewish Hospital and WashU Medicine, has received a nearly $1.5 million grant from the Robert J. Kleberg, […]
In the Media
FDA grants breakthrough therapy designation to treatment for rare blood cancers
Recognition follows strong early clinical results for a novel off-the-shelf CAR T therapy targeting rare and aggressive T-cell malignancies A novel off-the-shelf CAR T-cell therapy pioneered at Siteman Cancer Center at Barnes-Jewish Hospital and WashU Medicine is gaining national recognition after delivering striking clinical results in patients with rare and aggressive blood cancers. The FDA […]